Hematology White Papers & Case Studies

1. Rare Diseases Clinical Trial Services 12/17/2014

   Clinical development involving rare diseases poses a unique set of medical, scientific, and operational challenges. 

2. Point Of Care Hemoglobin Device Used In A Multicenter Study Of The Initiation Of Four Dosing Regimens Of ERYTHROPOIETIN Or The Treatment of Anemia Of Chronic Kidney Disease (CKD) 2/28/2012

   The primary objective of this study was to compare change in hemoglobin (Hb) from Baseline to the end of the study between the Q2W (every 2 weeks) and the Q4W (every 4 weeks) dosing regimens in subjects with anemia of CKD initiated on ERYTHROPOIETIN.

3. Point Of Care Coagulation For Standardized Monitoring And Dose Adjustment During A Clinical Trial Of A Low Molecular Weight Heparin 1/11/2012
   The study examined the use of a new low molecular weight heparin versus unfractionated heparin (UFH) among patients with ST-elevation myocardial infarction (STEMI) who had received fibrinolytic therapy and subsequently underwent percutaneous coronary intervention (PCI).
4. Trends In Clinical Practice: Growth Of POCT 11/23/2011
   Point-of-Care Testing (POCT) is most frequently defined as “clinical laboratory testing conducted close to the site of patient care, typically by clinical personnel whose primary training is not in the clinical laboratory sciences.
5. A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study For Evaluation Of Efficacy And Safety Of Study Drug Versus Warfarin In Subjects With Atrial Fibrillation 11/23/2011
   Atrial fibrillation (AF) is the most common type of arrhythmia in adults and becomes more common with increased age.
6. The Case For The Use Of Point-Of-Care Testing In Pharmaceutical Clinical Trials 11/22/2011
   Clinical trials that are designed to evaluate the efficacy of novel pharmaceuticals require a variety of diagnostic tests to be performed on all enrolled patients.